Glucagon stimulation test for the diagnosis of GH deficiency in adults - Conceicao, Silva, et al. - 2003 () Citation Context ...es GH release more effectively when administered intramuscularly or subcutaneously as opposed to the intravenous route [23]. The three studies utilizing the GST by ...
Guedon C, Schmitz J, Lerebours E, Metayer J, Audran E, Hemet J, Colin R 1986 Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastro- enterology 90:373–378 3. Raul F, Galluser M, ...
A positive anti-GAD test, as an indication of type 1 diabetes mellitus or latent autoimmune diabetes of the adult with progressive beta cell loss. 6. Previous GI surgery that could affect the ability to treat the duodenum, such as subjects who have had a Billroth II, Roux-en-Y gastric by...
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial eClinicalMedicine, Volume 54, 2022, Article 101691 Linong Ji,…, Lei ...
Center for Disease Control and Prevention. Quitting smoking among adults.https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a2.htm. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:Cd00...
Then we test the protein levels of p-IκBα, IκBα, and NF-κB (p65) under the TG treatment using the western blot. IκBα was an upstream target of NF-κB, its phosphorylation and degradation contribute to the activation of the NF-κB pathway. Compare to the control group, higher ...
In 2022, 48% of young adults reported to have tried vaping in the past 30 days compared to just 15% in 2019 (Statistics Canada, 2023). Inhaled vapor rapidly delivers nicotine to the brain, but as nicotine has a relatively short half-life of two hours (Benowitz, 2009), the time frame...
Boehringer Ingelheim, Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis, 2024. Available at https://www.boehringer-ingelheim.com/human-health/metabolic-diseases/survodutide-top-line-results-mas...
Jessup et al., “2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for ...
See, e.g., National Heart, Lung, and Blood Institute, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, The Evidence Report, Washington, D.C.: U.S. Department of Health and Human Services, NIH publication no. 98-4083 (1998). Another...